Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.medcli.2020.10.006 http://scihub22266oqcxt.onion/10.1016/j.medcli.2020.10.006 33308853!7833866!33308853     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Med+Clin+(Barc) 2021 ; 156 (4): 166-171 Nephropedia Template TP {{tp|p=33308853|t=2021. Incidencia de la COVID-19 en pacientes en tratamiento cronico con hidroxicloroquina |pdf=|usr=}}{{33308853}} gab.com Text Incidencia de la COVID-19 en pacientes en tratamiento cronico con hidroxicloroquina JO: Med Clin (Barc) http://www.kidney.de/pget.php?&tw=1&pmid=33308853 #FOAvip OBJECTIVE: To analyze the incidence of Covid-19 in patients who are chronic users of hydroxychloroquine. PATIENTS AND METHODS: Cross-sectional retrospective observational multicenter study in health areas and districts from Castilla La-Mancha and Andalucia. Of the 4451 participants included in the first recruitment, 3817 with valid data were selected. The main variable of the study is the presence or absence of Covid-19 infection by clinical, serological or polymerase chain reaction diagnosis. Sociodemographic and clinical variables and treatment and concomitant comorbidities were recorded. RESULTS: 169 (4,45%) patients had Covid-19 infection, of which 12 (7.1%) died and 32 (18.9%) required hospital admission. Previous respiratory pathology was related to Covid-19 infection (P<.05). Maculopathy appears in 5.3% of patients and is significantly related to the dose of hydroxychloroquine consumed (P<.05). CONCLUSION: There is no relationship between chronic use of hydroxychloroquine and the incidence of Covid-19. Twit Text FOAVip Incidencia de la COVID-19 en pacientes en tratamiento cronico con hidroxicloroquina ????Med Clin (Barc) http://www.kidney.de/pget.php?&tw=1&pmid=33308853 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33308853 #FOAvip English Wikipedia <ref>{{Cite pmid|33308853}}</ref> Incidencia de la COVID-19 en pacientes en tratamiento cronico con hidroxicloroquina #MMPMID33308853 Tejada Cifuentes F; Lloret Callejo A; Tirado Pelaez MJ; Rubio Pulido O; Ruiz-Morote Aragon M; Fernandez Urrusuno R; Munoz Carreras MI; Mendez Esteban MI; Maestre Sanchez V; Garcia Bonilla A; Paredero Dominguez JM; Arroyo Pineda V; Marco Tejon E; Romero Candel G; Fernandez Marchante AI; Marco Del Rio J; Ortiz Martin T; Lopez Sanchez P Med Clin (Barc) 2021[Feb]; 156 (4): 166-171 PMID33308853show ga OBJECTIVE: To analyze the incidence of Covid-19 in patients who are chronic users of hydroxychloroquine. PATIENTS AND METHODS: Cross-sectional retrospective observational multicenter study in health areas and districts from Castilla La-Mancha and Andalucia. Of the 4451 participants included in the first recruitment, 3817 with valid data were selected. The main variable of the study is the presence or absence of Covid-19 infection by clinical, serological or polymerase chain reaction diagnosis. Sociodemographic and clinical variables and treatment and concomitant comorbidities were recorded. RESULTS: 169 (4,45%) patients had Covid-19 infection, of which 12 (7.1%) died and 32 (18.9%) required hospital admission. Previous respiratory pathology was related to Covid-19 infection (P<.05). Maculopathy appears in 5.3% of patients and is significantly related to the dose of hydroxychloroquine consumed (P<.05). CONCLUSION: There is no relationship between chronic use of hydroxychloroquine and the incidence of Covid-19. |Adult[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |Antirheumatic Agents/*therapeutic use[MESH] |Arthritis, Rheumatoid/complications/*drug therapy[MESH] |COVID-19 Testing[MESH] |COVID-19/complications/diagnosis/*epidemiology[MESH] |Chronic Disease[MESH] |Cross-Sectional Studies[MESH] |Female[MESH] |Humans[MESH] |Hydroxychloroquine/*therapeutic use[MESH] |Incidence[MESH] |Lupus Erythematosus, Systemic/complications/*drug therapy[MESH] |Male[MESH] |Middle Aged[MESH] |Prognosis[MESH] |Protective Factors[MESH] |Retrospective Studies[MESH] |Risk Factors[MESH]Incidencia de la COVID-19 en pacientes en tratamiento cronico con hid(epmc).pdf DeepDyve Pubget Overpricing